631 related articles for article (PubMed ID: 26408837)
1. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study.
Zhang S; Zhai Z; Yang Y; Zhu J; Kuang T; Xie W; Yang S; Liu F; Gong J; Shen YH; Wang C
Int J Cardiol; 2016 Jan; 202():275-81. PubMed ID: 26408837
[TBL] [Abstract][Full Text] [Related]
2. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
[TBL] [Abstract][Full Text] [Related]
3. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors of venous thromboembolism recurrence and the predictive value of simplified pulmonary embolism severity index in medical inpatients].
Shi CL; Zhou HX; Tang YJ; Wang L; Yi Q; Liang ZA
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1112-5. PubMed ID: 27095779
[TBL] [Abstract][Full Text] [Related]
5. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.
Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD
Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588
[TBL] [Abstract][Full Text] [Related]
6. B blood group: A strong risk factor for venous thromboembolism recurrence.
Baudouy D; Moceri P; Chiche O; Bouvier P; Schouver ED; Cerboni P; Gibelin P; Ferrari E
Thromb Res; 2015 Jul; 136(1):107-11. PubMed ID: 25981188
[TBL] [Abstract][Full Text] [Related]
7. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES).
Franco Moreno AI; García Navarro MJ; Ortiz Sánchez J; Martín Díaz RM; Madroñal Cerezo E; de Ancos Aracil CL; Cabello Clotet N; Perales Fraile I; Gimeno García S; Montero Hernández C; Zapatero Gaviria A; Ruiz Giardín JM
Eur J Intern Med; 2016 Apr; 29():59-64. PubMed ID: 26775136
[TBL] [Abstract][Full Text] [Related]
8. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
[TBL] [Abstract][Full Text] [Related]
9. Short-term clinical outcome after acute symptomatic pulmonary embolism.
Conget F; Otero R; Jiménez D; Martí D; Escobar C; Rodríguez C; Uresandi F; Cabezudo MA; Nauffal D; Oribe M; Yusen R
Thromb Haemost; 2008 Nov; 100(5):937-42. PubMed ID: 18989541
[TBL] [Abstract][Full Text] [Related]
10. Warfarin Discontinuation in Patients With Unprovoked Venous Thromboembolism: A Large US Insurance Database Analysis.
Xie L; Liu X; Phatak H; Mardekian J; Tan W; Baser O; Ramacciotti E
Am J Ther; 2016; 23(6):e1744-e1753. PubMed ID: 26214203
[TBL] [Abstract][Full Text] [Related]
11. Risk of recurrence in patients with pulmonary embolism: predictive role of D-dimer and of residual perfusion defects on lung scintigraphy.
Poli D; Cenci C; Antonucci E; Grifoni E; Arcangeli C; Prisco D; Abbate R; Miniati M
Thromb Haemost; 2013 Feb; 109(2):181-6. PubMed ID: 23196319
[TBL] [Abstract][Full Text] [Related]
12. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.
Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; LE Gal G; Solymoss S; Crowther M; Perrier A; Ramsay T; Betancourt MT; White RH; Vickars L; Rodger MA
J Thromb Haemost; 2010 Sep; 8(9):1926-32. PubMed ID: 20561184
[TBL] [Abstract][Full Text] [Related]
13. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
Khan F; Tritschler T; Kimpton M; Wells PS; Kearon C; Weitz JI; Büller HR; Raskob GE; Ageno W; Couturaud F; Prandoni P; Palareti G; Legnani C; Kyrle PA; Eichinger S; Eischer L; Becattini C; Agnelli G; Vedovati MC; Geersing GJ; Takada T; Cosmi B; Aujesky D; Marconi L; Palla A; Siragusa S; Bradbury CA; Parpia S; Mallick R; Lensing AWA; Gebel M; Grosso MA; Shi M; Thavorn K; Hutton B; Le Gal G; Rodger M; Fergusson D
J Thromb Haemost; 2021 Nov; 19(11):2801-2813. PubMed ID: 34379859
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with low-molecular-weight heparin prolonged the survival time for acute pulmonary embolism patients concurrent with malignancy: an observational analysis from a long-term follow-up study.
Zhang S; Zhai Z; Yang Y; Zhu J; Gong J; Xie W; Kuang T; Wang C
Thromb Res; 2015 Apr; 135(4):582-7. PubMed ID: 25721935
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
[TBL] [Abstract][Full Text] [Related]
16. Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis.
Becattini C; Giustozzi M; Cerdà P; Cimini LA; Riera-Mestre A; Agnelli G
J Thromb Haemost; 2019 Aug; 17(8):1217-1228. PubMed ID: 31063646
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism.
den Exter PL; van Es J; Kroft LJ; Erkens PM; Douma RA; Mos IC; Jonkers G; Hovens MM; Durian MF; ten Cate H; Beenen LF; Kamphuisen PW; Huisman MV;
Thromb Haemost; 2015 Jul; 114(1):26-34. PubMed ID: 26017397
[TBL] [Abstract][Full Text] [Related]
18. The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE.
Yhim HY; Jang MJ; Kwak JY; Yim CY; Choi WI; Lee YC; Lee JO; Lee KW; Bang SM; Kim SH; Kim YK; Chang HJ; Oh D;
Thromb Res; 2013 Apr; 131(4):e133-40. PubMed ID: 23399441
[TBL] [Abstract][Full Text] [Related]
19. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.
Douketis JD; Gu CS; Schulman S; Ghirarduzzi A; Pengo V; Prandoni P
Ann Intern Med; 2007 Dec; 147(11):766-74. PubMed ID: 18056660
[TBL] [Abstract][Full Text] [Related]
20. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A
Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
